BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23041569)

  • 1. Degenerate recognition of MHC class I molecules with Bw4 and Bw6 motifs by a killer cell Ig-like receptor 3DL expressed by macaque NK cells.
    Maloveste SM; Chen D; Gostick E; Vivian JP; Plishka RJ; Iyengar R; Kruthers RL; Buckler-White A; Brooks AG; Rossjohn J; Price DA; Lafont BA
    J Immunol; 2012 Nov; 189(9):4338-48. PubMed ID: 23041569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA alleles determine differences in human natural killer cell responsiveness and potency.
    Kim S; Sunwoo JB; Yang L; Choi T; Song YJ; French AR; Vlahiotis A; Piccirillo JF; Cella M; Colonna M; Mohanakumar T; Hsu KC; Dupont B; Yokoyama WM
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3053-8. PubMed ID: 18287063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIR3DL01 recognition of Bw4 ligands in the rhesus macaque: maintenance of Bw4 specificity since the divergence of apes and Old World monkeys.
    Schafer JL; Colantonio AD; Neidermyer WJ; Dudley DM; Connole M; O'Connor DH; Evans DT
    J Immunol; 2014 Feb; 192(4):1907-17. PubMed ID: 24453246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
    Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
    J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques.
    Ries M; Reynolds MR; Bashkueva K; Crosno K; Capuano S; Prall TM; Wiseman R; O'Connor DH; Rakasz EG; Uno H; Lifson JD; Evans DT
    PLoS Pathog; 2017 Jul; 13(7):e1006506. PubMed ID: 28708886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif.
    Colantonio AD; Bimber BN; Neidermyer WJ; Reeves RK; Alter G; Altfeld M; Johnson RP; Carrington M; O'Connor DH; Evans DT
    PLoS Pathog; 2011 Mar; 7(3):e1001316. PubMed ID: 21423672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
    Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
    J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
    Sanjanwala B; Draghi M; Norman PJ; Guethlein LA; Parham P
    J Immunol; 2008 Nov; 181(9):6293-300. PubMed ID: 18941220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function.
    D'Amico S; D'Alicandro V; Compagnone M; Tempora P; Guida G; Romania P; Lucarini V; Melaiu O; Falco M; Algeri M; Pende D; Cifaldi L; Fruci D
    Front Immunol; 2021; 12():778103. PubMed ID: 34917091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules.
    Gwozdowicz S; Nestorowicz K; Graczyk-Pol E; Szlendak U; Rogatko-Koros M; Mika-Witkowska R; Pawliczak D; Zubala M; Malinowska A; Witkowska A; Nowak J
    Int J Immunogenet; 2019 Aug; 46(4):217-231. PubMed ID: 31210416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention.
    Taner SB; Pando MJ; Roberts A; Schellekens J; Marsh SG; Malmberg KJ; Parham P; Brodsky FM
    J Immunol; 2011 Jan; 186(1):62-72. PubMed ID: 21115737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.
    O'Connor GM; Vivian JP; Widjaja JM; Bridgeman JS; Gostick E; Lafont BA; Anderson SK; Price DA; Brooks AG; Rossjohn J; McVicar DW
    J Immunol; 2014 Mar; 192(6):2875-84. PubMed ID: 24563253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhesus macaque inhibitory and activating KIR3D interact with Mamu-A-encoded ligands.
    Rosner C; Kruse PH; Hermes M; Otto N; Walter L
    J Immunol; 2011 Feb; 186(4):2156-63. PubMed ID: 21257962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57.
    Kamya P; Boulet S; Tsoukas CM; Routy JP; Thomas R; Côté P; Boulassel MR; Baril JG; Kovacs C; Migueles SA; Connors M; Suscovich TJ; Brander C; Tremblay CL; Bernard N;
    J Virol; 2011 Jun; 85(12):5949-60. PubMed ID: 21471235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in
    Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B
    Front Immunol; 2018; 9():1855. PubMed ID: 30147699
    [No Abstract]   [Full Text] [Related]  

  • 16. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
    Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
    J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.
    Sharma D; Bastard K; Guethlein LA; Norman PJ; Yawata N; Yawata M; Pando M; Thananchai H; Dong T; Rowland-Jones S; Brodsky FM; Parham P
    J Immunol; 2009 Oct; 183(7):4569-82. PubMed ID: 19752231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro education of human natural killer cells by KIR3DL1.
    Pugh J; Nemat-Gorgani N; Djaoud Z; Guethlein LA; Norman PJ; Parham P
    Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31723004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC Class I Ligands of Rhesus Macaque Killer Cell Ig-like Receptors.
    Anderson JL; Sandstrom K; Smith WR; Wetzel M; Klenchin VA; Evans DT
    J Immunol; 2023 Jun; 210(11):1815-1826. PubMed ID: 37036309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells.
    Boulet S; Song R; Kamya P; Bruneau J; Shoukry NH; Tsoukas CM; Bernard NF
    J Immunol; 2010 Feb; 184(4):2057-64. PubMed ID: 20061407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.